Marker Therapeutics (MRKR) Research & Development (2010 - 2026)
Marker Therapeutics (MRKR) recorded Research & Development of $1.48 million in Q2 2026, down 64.7% from $4.18 million a year earlier and down 48.1% from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Research & Development (2010 - 2026) Analysis & Trends
On a TTM basis, Marker Therapeutics' Research & Development came in at $8.81 million as of Jun 30, 2026, down 44.5% year-over-year; for FY2025, it came in at $11.8 million, down 12.4% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of -9.0% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $13.47 million in FY2024 (+29.3%), $10.42 million in FY2023 (-13.0%), $11.97 million in FY2022 (-56.9%) and $27.79 million in FY2021 (+47.2%).
- The Q2 2026 figure is the lowest quarterly Research & Development since Q4 2017.
- On a year-over-year basis, Research & Development has declined for four consecutive quarters, with growth averaging 12.5% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 94.3% in Q4 2024, against a decline of 72.8% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.84 million (Q1 2026), $2.14 million (Q4 2025) and $2.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Marker Therapeutics | 17.87 Mn | -42.04 Mn | - | 1.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.48 Mn |
| Mar 31, 2026 | 2.84 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 2.35 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Mar 31, 2025 | 3.14 Mn |
| Dec 31, 2024 | 5.09 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 2.34 Mn |
| Mar 31, 2024 | 2.58 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | 2.38 Mn |
| Mar 31, 2023 | 3.38 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Sep 30, 2022 | 3.59 Mn |
| Jun 30, 2022 | 2.92 Mn |
| Mar 31, 2022 | 7.03 Mn |
| Dec 31, 2021 | 8.02 Mn |
| Sep 30, 2021 | 6.78 Mn |
API Access
Marker Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();